
Keywords: Chronic kidney disease; Drugs; Phosphate; Observational study; Cardiovascular risk; 1,25-OH-D; 1,25 dihydroxy vitamin D; API; active pharmaceutical ingredient; ATC; anatomic therapeutic class; ATP; adenosine triphosphate; CKD; chronic kidney disease; DDD;